Cancer cells simultaneously harbor global losses and gains in DNA methylation. We demonstrate that inducing cellular oxidative stress by hydrogen peroxide treatment recruits DNA methyltransferase 1 (DNMT1) to damaged chromatin. DNMT1 becomes part of a complex(es) containing DNMT3B and members of the polycomb repressive complex 4. Hydrogen peroxide treatment causes relocalization of these proteins from non-GC-rich to GC-rich areas. Key components are similarly enriched at gene promoters in an in vivo colitis model. Although high-expression genes enriched for members of the complex have histone mark and nascent transcription changes, CpG island-containing low-expression genes gain promoter DNA methylation. Thus, oxidative damage induces formation and relocalization of a silencing complex that may explain cancer-specific aberrant DNA methylation and transcriptional silencing.
INTRODUCTION
Elevated levels of reactive oxygen species (ROS) arising from alterations in cellular metabolism and inflammatory responses constitute a key risk state for increased cancer susceptibility (Federico et al., 2007) . The major forms of oxidative DNA damage are nonbulky lesions such as 8-oxo-2 0 deoxyguanosine (8-oxo-dG) and thymine glycol that are repaired predominantly by base excision repair (BER) (Reardon et al., 1997) .
The aforementioned DNA repair requires dynamic changes in surrounding chromatin, including changes in nucleosome positioning and histone modifications. The best-characterized chromatin alteration in DNA repair is the phosphorylation of the histone variant H2AX (g-H2AX) by DNA damage response protein kinases (Rogakou et al., 1998) . This modification helps stabilize the interaction of repair factors with the break sites, leading to further chromatin alterations. Histone acetylases and deacetylases also localize to sites of DNA damage to facilitate repair by increasing access of repair proteins to the break site, repressing transcription at sites of damage, restoring the local chromatin environment after repair is complete, and turning off the DNA damage response (Tamburini and Tyler, 2005) . In this regard, (Sirtuin-1) SIRT1 is a NAD + -dependent class III histone deacetylase that plays a role in gene silencing in cancer cells
Significance
Tumors have aberrant gains and losses in DNA methylation, but the mechanisms establishing these changes are not well understood. Here, we demonstrate that oxidative damage induces the formation of a large silencing complex(es) containing DNA methyltransferases and constituents of the polycomb complex, PRC4, including SIRT1. PRC4 is found uniquely in cancer and embryonic and adult stem cells. Key constituents of the damage-induced complex are recruited from transcriptionally poor regions of the genome to GC-rich areas, including promoter CpG islands. Such translocation causes changes in histone marks, transcription, and DNA methylation. We propose that this relocalization may be a mechanism by which oxidative damage is responsible for both promoter CpG island-specific hypermethylation and global hypomethylation seen in cancer. (Pruitt et al., 2006) and has been implicated in DNA damage repair in both yeast and mammalian cells. SIRT1 is recruited to sites of DNA damage and interacts with and deacetylates other proteins involved in the DNA damage response (for review, see Fan and Luo, 2010) . After DNA repair, DNA methylation also needs to be reestablished, possibly by the recruitment of the DNA methyltransferases (DNMTs) that catalyze CpG methylation, including DNMT1, which plays a role in methylating newly replicated DNA (Leonhardt et al., 1992) , and DNMT3A and DNMT3B, which are mostly responsible for de novo DNA methylation (Okano et al., 1999) . The aforementioned epigenetic players have been linked to patterns of cancer-related gene transcriptional silencing, in association with promoter CpG island DNA hypermethylation. We, and others, have shown that a large fraction of the genes that undergo promoter CpG Island DNA hypermethylation in cancer are unmethylated in embryonic stem and progenitor cells and held in low/ poised states of transcription by polycomb group (PcG) proteins (Ohm et al., 2007; Schlesinger et al., 2007; Widschwendter et al., 2007) . Importantly, SIRT1 has been described as part of a transformation-specific PcG complex, PRC4, which is found in embryonic and adult stem cells and cancer cells (Kuzmichev et al., 2005) . In addition to SIRT1, PRC4 contains the PcG proteins, Enhancer of Zeste protein-2 (EZH2), which catalyzes the trimethylation of lysine 27 of histone H3, and a specific isoform of EED (EED2) that is absent from previously identified PRC complexes. SIRT1 has also been shown to interact with DNMT1 (Espada et al., 2007) .The DNMTs have been linked to PcG proteins in the context of epigenetic gene silencing. Both DNMT1 and DNMT3B interact with EZH2, which in turn facilitates the binding of the DNMTs to EZH2 target promoters (Viré et al., 2006) .
In the present study, we investigate epigenetic alterations induced by the ROS, hydrogen peroxide (H 2 O 2 ), and by inflammation in mouse tissue. We examine changes in the interaction and chromatin binding of the epigenetic proteins discussed above and the functional consequences of these changes. This work attempts to determine a mechanism by which cancer risk states, such as chronic inflammation, can contribute to cancerrelated abnormal gene silencing and shifts in DNA methylation.
RESULTS

DNMT1 and SIRT1 Become Tightly Bound to Chromatin after H 2 O 2 Treatment
Previously, we have demonstrated that SIRT1 and DNMT1 are rapidly recruited to an induced double-strand break in an exogenous promoter CpG island construct (O'Hagan et al., 2008) . In this regard, SIRT1, similar to other proteins involved in DNA repair, is known to become more tightly bound to chromatin after oxidative stress (Oberdoerffer et al., 2008) . We now find, by examining resistance of the proteins to salt gradient extraction, that both SIRT1 and DNMT1 bind more tightly to chromatin in H 2 O 2 -treated human embryonic carcinoma cells (NCCIT) despite their unchanged whole-cell levels. As evidence of this tightening, after H 2 O 2 treatment, a portion of SIRT1 is redistributed from the cytoplasmic fraction to the soluble nuclear fraction and is present in all higher salt fractions ( Figure 1A) . Basally, as has been previously demonstrated, nuclear DNMT1 is loosely bound to the chromatin, being extracted by 0.3 and 0.45 M NaCl (Jeong et al., 2009) . However, after H 2 O 2 treatment, DNMT1 is also eluted in salt fractions of 0.6, 1.2, and 1.8 M NaCl ( Figure 1A ). HSP90 and LaminB serve as cytoplasmic and nuclear controls, respectively, for the extraction.
DNMT1 Functions Upstream of SIRT1 Recruitment to Chromatin following Oxidative Damage
We next queried the interdependency of the tightening of SIRT1 and DNMT1 to chromatin after H 2 O 2 treatment. SIRT1 knockdown or inhibition causes an increase in the fraction of DNMT1 tightly bound to chromatin after H 2 O 2 treatment relative to nonspecific shRNA or mock-treated cells, respectively (see Figures S1A-S1C available online). To examine these dynamics further, we utilized HCT116 cells genetically rendered hypomorphic for DNMT1 or fully deleted for DNMT3B (Rhee et al., 2002; Spada et al., 2007) . Although H 2 O 2 treatment recruits SIRT1 to the nucleus in the WT and DNMT3B KO lines, there is a significant reduction in nuclear SIRT1 in the DNMT1 hypomorph cells, both by biochemical fractionation ( Figure 1B ) and immunofluorescence ( Figure S1D ). However, the residual increase in nuclear SIRT1 in DNMT1 hypomorph cells suggests that additional DNMT1-independent mechanisms may exist for changes in SIRT1 localization after H 2 O 2 treatment. Furthermore, shRNA knockdown of DNMT1 in NCCIT cells significantly reduces the amount of SIRT1 that becomes tightly bound to chromatin after H 2 O 2 treatment to 0.5-fold of control while simultaneously leading to an increase in g-H2AX levels ( Figure 1C ). Although these results suggest that tightening of DNMT1 and SIRT1 binding to chromatin after H 2 O 2 treatment are dependent on each other, DNMT1 appears to be necessary for the increase in binding of SIRT1 to chromatin.
Because ROS induces DNA damage in the form of base damage, single-strand breaks, and double-strand breaks, we next examined other types of DNA-damaging agents and found that neither ionizing radiation nor ultraviolet light increase the tightness of binding of DNMT1 or SIRT1 to chromatin (Figures S1E and S1F) . Additionally, inhibition of poly (ADP-ribose) polymerase (PARP), an enzyme involved in DNA repair of singleand double-strand breaks, or knockdown of key components of NER does not affect DNMT1 or SIRT1 recruitment to chromatin after H 2 O 2 treatment (data not shown). Interestingly, we demonstrate that H 2 O 2 treatment induces a significantly higher level of DNMT1 in the tight chromatin fraction in cells overexpressing c-Myc-tagged OGG1, the DNA glycosylase responsible for excising 8-oxo-dG during BER, compared to empty vector cells ( Figure 1D ). However, OGG1 overexpression does not affect the tightness of SIRT1 binding to chromatin, possibly because the chromatin-bound levels of this protein are saturated after H 2 O 2 treatment and, therefore, cannot be increased further by more DNMT1 recruitment.
DNMTs, SIRT1, and Polycomb Members Interact, as Part of a Large Multiprotein Complex(es), after H 2 O 2 Treatment Having demonstrated that H 2 O 2 treatment induces a DNMT1-influenced recruitment of SIRT1 to chromatin, we now queried whether such treatment might facilitate interactions between the two proteins and with other partners. We first observe, using DNMT1 coimmunoprecipitations (coIPs) from NCCIT cells after H 2 O 2 exposure, a time-dependent interaction between endogenous DNMT1 and endogenous SIRT1, 30 and 60 min after treatment ( Figure 2A) . We further validate this interaction by expressing a FLAG-tagged full-length DNMT1 in the DNMT1 hypomorph HCT116 cell line and finding that H 2 O 2 treatment results in the interaction between the tagged DNMT1 protein and endogenous SIRT1 ( Figure 2B ).
We broadened our search for interacting proteins based on the previously mentioned association between DNA-hypermethylated genes and PcG marks. In this regard we observe that H 2 O 2 treatment increases the interaction of DNMT1 with EZH2 and EED ( Figure 2B ). Further evidence for SIRT1 in this complex is demonstrated by immunoprecipitated endogenous nuclear SIRT1 pulling down increased levels of DNMT1, EZH2, SUZ12, and the PRC4-specific isoform of EED, EED2, after H 2 O 2 treatment ( Figure 2C ; Figures S2). Total cellular levels of the aforementioned proteins do not change after treatment ( Figure 1A ; data not shown). Initially, our entré e toward recognition of these interactions was based upon our previous demonstration that there is an acute recruitment of DNMT3B to an induced double-strand break, which is dependent on SIRT1 (O'Hagan et al., 2008) . We now find that H 2 O 2 treatment of NCCIT cells results in an endogenous interaction between SIRT1 and DNMT3B, as analyzed by immunoprecipitation of DNMT3B. This interaction is detectable within 5 min and increases up until 30 min after treatment ( Figure 2D ). As has been shown previously, DNMT3B and DNMT1 also interact (Kim et al., 2002) , and this interaction does not change with treatment ( Figure 2D ). Our DNMT3B coIP also reveals that the aforementioned interactions occur in the context of PRC4 because there is strong interaction of DNMT3B with EZH2, SUZ12, and EED2, both before and after H 2 O 2 treatment ( Figure 2D ).
The triggering of multiple, individual interactions suggests the H 2 O 2 -induced generation of a possible mega-complex(es). To examine this hypothesis, we separated nuclear protein complexes by size using sucrose gradient centrifugation from (A) NCCIT cells were untreated (U) or treated with 1 mM H 2 O 2 for 30 min (T). Cell pellets were extracted sequentially using cytoplasmic extraction buffer (Cyto), soluble nuclear buffer (nuclear unbound), and buffers with increasing NaCl concentration. Whole-cell lysates were prepared separately (WCE).
(B) HCT116 (WT), HCT116 hypomorphic DNMT1 (MT1 hypo), and HCT116 DNMT3B KO (3B KO) cells were treated with H 2 O 2 at the indicated concentrations (conc.) in millimolars (mM) for 30 min, and total nuclear protein was collected. y axis is SIRT1 over Actin levels relative to 8 mM treated WT cells. The data presented are the mean of three independent experiments ± SEM. *p < 0.05 by one-tailed t test. (C) NCCIT cells were infected with nonspecific shRNA (NS) or DNMT1 shRNA. After 72 hr, they were untreated (Unt) or treated with 1 mM H 2 O 2 for 30 min (H 2 O 2 ). Tight chromatin is the remaining protein in the chromatin pellet after extraction with 0.45 M NaCl buffer. Band densitometry values are displayed as the ratio of DNMT1 knockdown over NS knockdown for protein levels in H 2 O 2 -treated cells. The data presented are the mean of three independent experiments ±SEM. *p < 0.05 by one-tailed t test. (D) NCCIT cells were transiently transfected with empty vector (EV) or c-Myc-tagged OGG1 (Myc-OGG1) plasmids for 48 hr followed by 1 mM H 2 O 2 treatment and analysis as in (C). # Myc-OGG1. *p < 0.05 by one-tailed t test.
See also Figure S1 .
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Oxidative Damage Targets Complexes to CpG Islands untreated and H 2 O 2 -treated cells. After H 2 O 2 treatment, DNMT1, SIRT1, and DNMT3B, and to a lesser extent SUZ12, EZH2, and EED proteins all migrate in the gradient in regions of higher molecular mass (greater than 650 kDa) than in untreated cells ( Figure 3A ). When we perform DNMT3B coIP on pooled fractions from the gradient in untreated cells, the majority of the PcG proteins (EZH2, SUZ12, and EED2) and DNMT1 coimmunoprecipitate with DNMT3B in lower molecular weight pools 1 and 2 (smaller than 650 kDa, left panel in Figure 3B ). Importantly, after treatment, the coIP between DNMT3B and the PcG members and DNMT1 now shifts toward pools 2 and 3, indicating interaction of the proteins in a much larger complex(es) (middle panel in Figure 3B ). After treatment, SIRT1 interacts with DNMT3B in the pools 2 and 3 (middle panel in Figure 3B ), suggesting that all DNMT3B-interacting members are present in the same-sized large complex(es) after H 2 O 2 treatment.
To examine the aforementioned complex formation further, we performed similar gradient analyses and coIPs of DNMT1 in the DNMT1 hypomorph HCT116 cell line exogenously expressing FLAG-tagged full-length DNMT1. The input protein analyses for this coIP indicate that there is more nuclear DNMT1, SIRT1, and EZH2 in the higher molecular weight gradient fractions after H 2 O 2 treatment than before treatment (right panel in Figure 3C ). In untreated cells the majority of FLAG-DNMT1 is immunoprecipitated from lower molecular weight gradient pools 1 and 2 and interacts with EZH2 in pools 1, 2, and 3 (left panel in Figure 3C ). As expected, SIRT1 is not seen prior to treatment. After H 2 O 2 treatment, FLAG-DNMT1 is now immunoprecipitated more prominently from pool 3 in addition to pools 1 and 2, peak interaction of EZH2 with FLAG-DNMT1 is now in pool 3, and interaction is seen with SIRT1 in pools 2 and 3 (middle panel in Figure 3C ). Thus, as for DNMT3B, DNMT1 interacts with EZH2 and SIRT1 as part of a large multiprotein complex(es) after H 2 O 2 treatment. To demonstrate that DNMT1, EZH2, and SIRT1 were indeed all bound together in these large complexes, we performed sequential coIP in the FLAG-DNMT1 cells. First, we immunoprecipitated DNMT1-containing complexes. After eluting these complexes, we immunoprecipitated EZH2-interacting proteins. As demonstrated by the SIRT1 band in the EZH2 IP lane in the DNMT1 elute from the treated cells, EZH2 that is bound to DNMT1 after H 2 O 2 treatment is also bound to SIRT1 ( Figure 3D ). In total these data suggest that oxidative damage induces the formation of a large complex(es) containing the DNMTs and PRC4 members.
DNMT1, SIRT1, and EZH2 Form DNA Damage Foci
To determine the possible interactions of DNMTs and members of PRC4 directly with DNA damage sites, we performed coimmunofluorescence of key interacting proteins with g-H2AX in NCCIT cells. We used a paraformaldehyde fixation method that does not visualize DNA replication foci because DNMT1 is constitutively present at these sites in S phase ( Figure S3A ). After H 2 O 2 treatment, the chromatin-bound protein, LaminB, does not colocalize with g-H2AX foci ( Figure S3B ). In contrast there is an increase in total nuclear DNMT1, and in DNMT1 foci (0.3 foci in untreated and 4.1 in treated cells; Figure 4B ), the majority of which colocalizes with g-H2AX ( Figure 4C ). The PcG member, (B) Fractions from (A) were pooled into five groups as indicated at the bottom of (A). coIPs for control IgG or anti-DNMT3B (3B) antibodies were performed from the pooled fractions. Right panels are inputs from the pooled fractions. The number sign (#) represents isoform 2 of EED. (C) HCT116 DNMT1 hypomorph cells expressing FLAG-DNMT1 were untreated or treated with 8 mM H 2 O 2 for 30 min. Nuclear extracts, sucrose gradients, and pooling of fractions were performed as in (A). coIPs for control IgG or anti-FLAG (Fl) antibodies were performed from pooled fractions. Right panels are inputs from the pooled fractions.
(D) FLAG coIPs were performed in HCT116 DNMT1 hypomorph cells expressing FLAG-DNMT1 that were either untreated (U) or treated with 8 mM H 2 O 2 for 30 min (T). After elution with FLAG peptide (elute), a second immunoprecipitation was done using IgG or EZH2 antibodies. The number sign (#) represents isoform 2 of EED. EZH2, behaves similarly to DNMT1 (1.8-4.0 foci per cell) ( Figures  4A-4C ). SIRT1, also, exhibits occasional larger foci after H 2 O 2 treatment that colocalize with g-H2AX ( Figure 4A ), but the considerable increase in nuclear staining makes precise quantitation difficult. Dense and widely distributed nuclear staining of DNMT3B before and after treatment did not allow visualization of foci after treatment. Overall, it appears that the tight binding of DNMT1 and SIRT1 to chromatin induced by H 2 O 2, and the interaction between these two proteins and other PcG components, occur, at least in part, at DNA damage sites.
Oxidative Damage Recruits Members of the H 2 O 2 -Induced Silencing Protein Complex to Promoter CpG Islands We next explored the genomic regions to which the oxidative damage-induced complexes may localize using the SW480 colon carcinoma cell line, where we have observed similar tightening of DNMT1 and SIRT1 to chromatin after H 2 O 2 treatment ( Figure S4A ). We first find, utilizing customized chromatin immunoprecipitation (ChIP)-chip arrays for chromosome 18, 19, and 21, and histone H3 as a control, damage-induced concurrent shifts for DNMT1, DNMT3B, SIRT1, and g-H2AX after H 2 O 2 treatment ( Figure 5A ; Figure S4B ). In each case the chromosome regions with enrichment constitute those previously mapped by others (Folle et al., 2010) to harbor high gene transcription activity and GC content. This enrichment shift is particularly observable for chromosome 21, where the subtelomeric regions of the chromosome harbor most of the gene transcription and GC content ( Figure 5A ). Importantly, concomitant to the coenrichments above, there is a notable loss of the same silencing proteins from the transcriptionally inactive and GC-poor regions ( Figure 5A ). For all three chromosomes examined, changes in ChIP signals are most prominent around the transcription start sites (TSSs) of genes (example for DNMT1 signals in Figure S4C ). To explore this finding in more depth, we used promoter arrays to examine the colocalization of the proteins at gene promoters across the genome. In these promoter studies we included one of the key PcG members, EZH2. We also matched the results to previously obtained genome-wide expression array data (Easwaran et al., 2010) . These studies not only confirm targeting of all the tested proteins, after damage, to transcriptionally active GC-rich promoter regions but also extend our findings in key ways.
First, DNMT1, DNMT3B, SIRT1, EZH2, and g-H2AX enrichment that is lost from transcriptionally poor and low GC content regions is translocalized to the promoters of genes that contain CpG islands and are highly expressed, with a high degree of overlap of enrichment between the different proteins ( Figures  5B-5E ). The direct targeting to promoter CpG islands can be appreciated for the high expression example genes, MYC, ACTB, RPL13, and RPL10A ( Figure 5D , left panel). The loss of enrichment for low-expression, non-CpG island promoter genes is well appreciated for the example genes, HBB, HBD, LAMB4, IL8, and MYH1 ( Figure 5D, right panel) . These genomic analyses were confirmed by local ChIP and quantitative PCR ( Figure S4D ).
Second, transcriptional activity is associated with targeting of the members of the complex separately from the presence of CpG islands ( Figure 5E ; Figures S4E and S4F) . We find that high-expression genes gain more enrichment than low-expression genes in groups of genes both with and without CpG islands ( Figure 5E , left and middle panels). However, the presence of CpG islands is still important because targeting is increased in CpG island versus non-CpG island genes with similar low basal expression ( Figure 5E , right panel; Figure S4F ). Further scrutiny of the pattern of translocalization revealed that the position of peaks also correlates with areas of high GC content, including but not limited to CpG islands ( Figure 5D [note gene ACTB]; Figure S4G) , indicating that GC content, in addition to the presence of CpG islands, is a contributing factor to targeting. Altogether, these data suggest that members of the complex undergo H 2 O 2 -induced enrichment at gene promoters with high expression and/or high GC content, including those with CpG islands.
Functional Consequences of Enrichment of Members of the Oxidative Damage-Induced Complex
The fact that oxidative damage induces proteins involved in gene silencing to form a complex and be enriched at CpG island-containing promoters suggests a potential functional role of this complex in transcriptional changes accompanying DNA damage and/or cancer-specific, abnormal gene silencing. Examination of changes in histone marks, transcription, and DNA methylation supports this hypothesis.
We first examined histone modifications at CpG islandcontaining gene promoters most targeted by members of the complexes. Using genome-wide promoter arrays and histone H3 to normalize for nucleosome positions, we observed, as expected, marked relative enrichment for the active transcription marks, 3MeK4H3 and AcK16H4, and low amounts of the PcG repressive mark, 3MeK27H3, at the promoter of high-expression genes in untreated cells ( Figure S5A ). After treatment, there is reduction in the active marks 3MeK4H3 and AcK16H4, the latter is consistent with the deacetylation activity of SIRT1, and enrichment of the H3K27me3 mark, which can be catalyzed by the PcG component EZH2 ( Figure 6A ). These global changes are verified by examining patterns at the CpG island-containing promoters of genes, including MYC, ACTB, SFRP4, MLH1, SFRP5, and TIMP3 ( Figure 6B ), and by local ChIP studies ( Figure S5B) . We see similar changes, although with less magnitude, for See also Figure S4 .
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Oxidative Damage Targets Complexes to CpG Islands high-expression non-CpG island genes ( Figure S5C , left panel).
Interestingly, there appears to be a slight gain in 3MeK4H3 and loss of 3MeK27H3 ( Figure S5C , right panel) at low-expression non-CpG island gene promoters, where there is relative decrease in the complex constituents ( Figure 5E , right panel).
To further relate these histone mark changes to oxidative damage, we also demonstrate that 8-oxo-dG is enriched at promoter CpG islands of candidate high expression genes ( Figure S5B) . Second, the change in 3MeK4H3 levels suggests that enrichment of members of the complex may also rapidly induce repressive transcriptional changes mainly in CpG island-containing Figure 5C except that ChIP over input signals are normalized to H3. Red and blue represent the top 100 CpG island genes with high and low expression, respectively. *p < 2 3 10 À10 by two-tailed t test.
(B) Plots are constructed as in Figure 5D with ChIP signals normalized to H3. (C) SW480 cells were either untreated or treated with 2 mM H 2 O 2 for 30 min, and the nascent RNA was labeled concurrently. Quantitative RT-PCR data are presented as the mean of the log2 ratio of the treated over the untreated values for three independent biological replicates ±SEM. *p < 0.05 by one-sided t test. (D) Plots are constructed as in Figure 5D . (E) Bisulfite sequencing was performed on DNA from SW480 cells that were untreated or treated with 2 mM H 2 O 2 for 30 min. Results are shown as a combination of three independent biological replicates with at least eight clones per experiment. Circles are the individual clones. Black horizontal lines are the mean for all clones with the vertical line representing the SEM. p values by one-sided Welch's t test for MLH1, SFRP5, and SFRP4 are 0.014, 0.012, and 0.005, respectively. The gradient bar at the bottom depicts the relative log2 basal expression levels, by expression array, which are 11.13, 6.82, and 6.40 for MLH1, SFRP5, and SFRP4, respectively. See also Figure S5 .
genes with significant basal expression. Indeed, the CpG islandcontaining genes, MYC, ACTB, TIMP3, and MLH1, all have reduced nascent transcription levels within 30 min after treatment ( Figure 6C ). In contrast the low expression non-CpG island-containing genes, NANOG, HBD, and IL8, either gain or have no change in their nascent transcription levels, suggesting that the reduction in transcription for high-expression genes is not solely due to a global DNA damage-induced decrease in transcription ( Figure 6C ). Third, we find important correlates for genes that develop cancer-specific, abnormal, CpG island DNA hypermethylation. Genes with a high frequency for this change in colon cancer that are unmethylated or hypermethylated in SW480 cells have damage-induced enrichment of the silencing proteins ( Figure 6D ; Figure S5D ).
Fourth, we examined DNA methylation by bisulfite sequencing for representative genes. We did not observe any CpG methylation in the promoter CpG island of the high-expression gene, MYC, which does not become hypermethylated in cancer (data not shown). However, at the short time point examined, we find increases in DNA methylation for the MLH1, SFRP5, and SFRP4 genes, which are frequently hypermethylated in colon cancer but are unmethylated in SW480 cells ( Figure 6E ). These three genes are basally expressed to varying degrees in SW480 cells, and the level of observed increases in DNA methylation is inverse to this expression ( Figure 6E ). This finding fits well with emerging data that cancer-specific, promoter DNA methylation mostly targets genes, which normally have low basal expression (Hahn et al., 2008) . These data suggest that localization of members of the complex to gene promoters has functional consequences, including histone mark changes, reduction in nascent transcription, and/or increases in DNA methylation.
Inflammation-Induced Changes in EZH2, SIRT1, and DNMT1 in a Mouse Model of Colitis
To examine whether our in vitro findings are applicable to the cancer risk state of inflammation, we studied an in vivo model of colitis in which infection with the human commensal enterotoxigenic Bacteroides fragilis (ETBF) induces inflammation and tumorigenesis primarily in the distal colons of Multiple intestinal neoplasia (Min) mice, which are heterozygous for loss of Adenomatous polyposis coli (Apc) Wu et al., 2009) . Importantly, in vitro treatment of colon cancer cells with purified B. fragilis toxin induces an increase in g-H2AX and ROS, suggesting that this model provides an in vivo scenario to assess the endogenous impact of the oxidative damage we examined in our in vitro model (Goodwin et al., 2011) . First, we examined whether any of the players involved in our complex become more tightly bound to chromatin in the inflamed distal tissue ( Figure S6A ). Similar levels of Villin, an epithelial marker, establish that cells harvested by scraping from ETBF and mock-inoculated (sham) mice have similar epithelial content, though this method does not obtain pure populations of epithelial cells ( Figure S6B ). Using the salt gradient extraction employed in Figure 1A , whereas we detect no change in DNMT1 (data not shown), we demonstrate that both SIRT1 and EZH2 are more tightly bound to chromatin in distal, but not proximal, colon epithelial cells from ETBF mice than sham mice 2 days after inoculation ( Figure 7A ; Figures S6B and   S6C ). These results suggest the change in binding is due to the specific high level of inflammation that occurs during the acute phase of the ETBF model. Second, we examined whether any of the proteins in our complex interact in the inflamed tissue. We performed coIPs using anti-EZH2 antibodies in proximal or distal colon epithelial cells from two separate pairs of sham and ETBF mice. Although in all cases EZH2 coimmunoprecipitates predominantly isoform 1 of EED (isoform is determined by comparison to the four isoforms present in mouse embryonic carcinoma cells; Figure S6D ), coIP of DNMT1 by EZH2 is more prominent in the tissue from the distal colon of the ETBF mice ( Figures 7B and S6D ), suggesting that this interaction is increased by the inflammation in this tissue.
Third, we performed local ChIP for EZH2 and DNMT1 in epithelial cells from the distal colon of ETBF and sham mice. Interestingly, unlike the in vitro model, we do not see enrichment of EZH2 and DNMT1 at all promoter CpG islands ( Figure 7C ). High-expression housekeeping genes such as Actb and Gapdh have no change in EZH2 or DNMT1 enrichment between the ETBF and sham mice. However, lower-expression genes, such as Fbn1, Sez6l, Sfrp5, and Sox17, that have higher basal levels of EZH2 than the high-expression genes, all have more enrichment of EZH2 and DNMT1 at their promoter CpG islands in inflamed distal epithelial cells from ETBF mice compared to sham mice. Interestingly, three of these genes, Fbn1, Sez6l, and Sox17, have been demonstrated to undergo inflammation and tumor-specific DNA methylation in a model of intestinal inflammation, and all four are methylated in human cancers (Hahn et al., 2008) . These data suggest that in this model, where changes in ROS are likely less dramatic and induced over a longer time frame than for our in vitro model, the recruitment of members of the silencing complex is most persistent at promoter CpG island-containing genes with lower basal expression. These genes are the most likely to be targets of cancer-specific DNA methylation (Hahn et al., 2008) .
DISCUSSION
In the present study, we link several proteins involved in transcriptional repression to the DNA damage response. We provide evidence for a role for DNMT1 in the response of cells to H 2 O 2 treatment. This enzyme becomes more tightly bound to chromatin after H 2 O 2 treatment in the context of damage-induced foci that colocalize with g-H2AX. Moreover, DNMT1 appears responsible for the tightening of the PRC4 component, SIRT1, to chromatin after H 2 O 2 treatment. SIRT1 has been implicated in the response to DNA damage and transcriptional repression in many ways as previously discussed. Although in inflamed mouse tissue we do not see an increase in binding of DNMT1 to chromatin, we see an increase in binding of the PRC4 components, SIRT1 and EZH2. Increases in binding of DNMT1 to chromatin may occur at an earlier time point than the one we studied because the in vivo model time point is 2 days after infection compared to 30 min after treatment for our in vitro model. However, we do implicate DNMT1 in the in vivo response to colonic inflammation by demonstrating interaction between EZH2 and DNMT1 and enrichment of both of these proteins at the CpG islands of low-expression genes in the inflamed tissue, in a manner consistent with our in vitro results.
Our observations presented here suggest that tightening of DNMT1 and SIRT1 to chromatin after H 2 O 2 treatment is actively associated with DNA damage and/or repair. Our evidence by immunofluorescence studies for colocalization of DNMT1, SIRT1, and EZH2 to DNA damage-induced foci marked by g-H2AX suggests targeting to ongoing DNA damage. Previously, See also Figure S6 .
we have implicated DNMT1 in double-strand break repair, and recently, another group has further studied this role for DNMT1 (Ha et al., 2011; O'Hagan et al., 2008) . We did not see DNMT1 become more tightly bound to chromatin after IR treatment, and the observed narrow localization of g-H2AX signal at the promoter region by ChIP-chip after H 2 O 2 exposure is not representative of the typical mega base domain enrichment seen after double-strand breaks (Rogakou et al., 1999) . Thus, our findings suggest that, after H 2 O 2 treatment, double-strand breaks are not the dominant trigger for the dynamics we are reporting. Because levels of OGG1 modulate the tightening of DNMT1 binding to chromatin, we suggest that either the specific 8-oxo-dG base damage or the BER pathway that repairs this type of damage is responsible for the recruitment of the members of the silencing complex to chromatin. We propose that the promoter-targeted g-H2AX is likely marking sites of base damage, and this hypothesis is supported by the enrichment of 8-oxo-dG at GC-rich promoters after H 2 O 2 treatment. We suggest that the enrichment of damage at these areas of high GC content may be because guanine is the most easily oxidized of the four deoxyribonucleosides and, therefore, may be targeted by oxidative damage (Steenken, 1997) . The coenrichment of DNMT1, SIRT1, DNMT3B, and EZH2 at these sites suggests that these proteins are being localized to sites of base damage induced by H 2 O 2 treatment. Although in our in vivo model we have not assessed whether the enrichment of key complex constituents is also occurring at the sites of base damage, it has been demonstrated that purified B. fragilis toxin causes an increase in g-H2AX and ROS in colonic epithelial cells. These data suggest that our in vivo model involves a similar induction of oxidative damage as our in vitro model (Goodwin et al., 2011) . One of the intriguing implications of our data is the potential role for increased levels of cellular ROS that accompany cancer risk states such as inflammation in the formation of cancerspecific aberrant patterns of DNA methylation and transcriptional silencing. First, as we have noted, cellular transformation has been associated with the presence of the PRC4 iso-complex (Kuzmichev et al., 2005) that we now link to DNMTs during H 2 O 2 exposure. This complex has altered substrate specificity from the typical PRC2/3 complexes possibly due to the specific isoform of EED that it contains (EED2) (Kim et al., 2007) . Because both preneoplastic and transformed cells undergo a significant amount of endogenous oxidative damage (Federico et al., 2007) , the basal PRC4 previously described in transformed cells may be the same as the complex we describe here. Because nuclear SIRT1 levels increase after H 2 O 2 treatment, it is possible that the increase in interaction demonstrated between SIRT1 and the other proteins in Figure 2 is due to higher levels of SIRT1, not to an induced interaction per say. However, either cause has the same outcome, namely higher levels of the complex.
Second, our findings suggest one potential mechanism that might help explain a conundrum in the abnormalities of DNA methylation in human cancer-namely, why cancer cells simultaneously harbor both widespread chromosomal loss of DNA methylation and increased DNA methylation in CpG islands of gene promoters (Jones and Baylin, 2007) . In terms of the losses, we find that enzymes that catalyze DNA methylation, DNMT1 and DNMT3B, shift away from non-GC-rich gene and chromosome regions. In a similar manner it has previously been demonstrated in yeast and mammalian cells that DNA damage leads to a shift in localization of SIRT1 from repressed gene regions to sites of induced DNA damage, resulting in transcriptional derepression of genes that are basally repressed by SIRT1 (Mills et al., 1999; Oberdoerffer et al., 2008) . We suggest that when cells are exposed to chronic oxidative damage that is present during all phases of tumorigenesis, the induced shifts in chromosome localization that we demonstrate may be associated with losses of DNA methylation observed in cancer cells.
Finally, our observations may also help explain gains in DNA methylation at gene promoters in cancer cells. By examining histone mark and transcription changes, we demonstrate that enrichment of members of this silencing complex is associated with gene silencing. However, importantly, in cells progressing toward transformation, the aforementioned translocalization would probably be transient at most genes with high basal transcription levels, such as housekeeping genes, and oncogenes, for which silencing would be detrimental to tumor cell growth. This hypothesis is supported by the lack of EZH2 and DNMT1 enrichment at the promoters of high-expression CpG islandcontaining genes in the less harsh, longer time frame, inflammatory in vivo model studied. In this regard, active transcription may prevent de novo promoter CpG island methylation (Thomson et al., 2010) . We demonstrate that genes with a history of frequent, cancer-specific, CpG island promoter DNA hypermethylation show damage-induced enrichment for the members of the complex in cell culture and enrichment of EZH2 and DNMT1 in inflamed mouse tissue. In vitro we see an increase in DNA methylation that correlates with the low basal expression level of these genes, which harbor PcG complexes in embryonic stem and progenitor cells (Ohm et al., 2007; Schlesinger et al., 2007; Widschwendter et al., 2007) . We hypothesize that such localization of the DNMT-PRC4 complex and increase in DNA methylation at low-expression promoter CpG island-containing genes might be more persistent over the course of chronic ROS damage during tumorigenesis, setting up a scenario for the expansion of DNA methylation in the CpG islands involved. Our previous work with a promoter CpG island, double-strand break DNA damage model suggests this time-dependent context for the expansion of such DNA hypermethylation (O'Hagan et al., 2008) .
EXPERIMENTAL PROCEDURES
Cell Culture, Chemicals, Treatments, and Plasmids Cells were maintained as described in the Supplemental Experimental Procedures. The DNMT1 hypomorph HCT116 cell line was clonally selected for stable expression of exogenous FLAG-tagged full-length DNMT1 and maintained in media containing puromycin. For H 2 O 2 exposure, 30% H 2 O 2 (Sigma-Aldrich) was diluted in PBS immediately before adding it to the medium. Time of treatment is the time after H 2 O 2 is added to the media. c-Myc-Nuc-hOGG1 (Chatterjee et al., 2006) was kindly provided by D. Sidransky (Addgene plasmid 18709).
Salt Gradient Extraction and Tight Chromatin Fractionation
Cells were collected 30 min after H 2 O 2 exposure and subjected to sequential extraction with buffers indicated in the Supplemental Experimental Procedures. Band densitometry for western blots was analyzed using ImageJ software.
shRNA Knockdown Cells were transduced with the indicated lentiviral particles following the manufacturer's protocol (Sigma-Aldrich). coIP coIPs were performed from nuclear extracts that were treated with oligoamines to release chromatin-bound proteins as described in the Supplemental Experimental Procedures.
Sucrose Gradient
Nuclear extracts prepared as for coIP were applied to a 15%-60% (w/v) sucrose gradient, and centrifuged in a SW41 rotor for 20 hr at 40,000 rpm at 4 C. Equivalent volumes from each odd fraction were separated by SDS-PAGE and analyzed by immunoblot. The remaining fractions were pooled as indicated. Buffer was exchanged to modified RIPA using PD-10 columns (GE Healthcare). coIPs were performed from each pool as in the section above.
Immunofluorescence Cells grown on coverslips were pre-extracted and fixed as described in the Supplemental Experimental Procedures.
ChIP-chip
Cells were crosslinked using 1% formaldehyde and 0.5 mM DSG. Nuclear extraction was performed using CEBN and CEB, followed by ChIP-chip as previously described (McGarvey et al., 2008) using antibodies indicated in Supplemental Experimental Procedures. Samples were either hybridized to the Agilent 1M custom array for human chromosomes 18, 19, and 21 or the human promoter 244K or 1M ChIP-chip arrays from Agilent Technologies.
Nascent Transcription
Nascent transcription assays were performed using the Click-iT Nascent RNA Capture Kit (Invitrogen). Cells were labeled with ethynyl uridine for 30 min concurrently with the H 2 O 2 treatment if indicated.
Bisulfite Sequencing
Bisulfite treatment was performed with the EZ DNA Methylation Kit (Zymo). Bisulfite sequencing was performed as previously described .
Mice C57BL/6J mice were handled and inoculated as in Rhee et al. (2009) . Distal and proximal epithelium was collected by scraping the mucosal surface of the dissected colon, washed three times in PBS, and then subjected to the indicated protocol. Such scraping has been shown by others to be an effective method to obtain samples of intestinal epithelial cells (Ortega-Cava et al., 2006) . ChIP from this tissue was performed using the Magna ChIP G Tissue Kit (Millipore). All mouse protocols were approved by the Johns Hopkins University Animal Care and Use Committee in accordance with the Association for Assessment and Accreditation of Laboratory Animal Care International.
Statistical Analysis
All western blot, immunofluorescence, and local ChIP data are presented as the mean ± standard error of the mean (SEM). These data are evaluated by one-tailed t test and considered statistically significant with a p value <0.05. ChIP-chip data were analyzed utilizing the limma and Ringo packages from Bioconductor (Smyth and Speed, 2003; Toedling et al., 2007) as described in the Supplemental Experimental Procedures.
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Microarray data sets were deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (GEO) database (http://www.ncbi. nlm.nih.gov/geo) with the accession number GSE32382.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at doi:10.1016/j.ccr.2011. 09.012.
